fashion -WSS

fashion

author：fashion 2025-10-06 11:34:44 Page View：62887

A dosage of Wegovy, a drug used for weight loss — Amanda Andrade-Rhoades/AP

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Harvard scientists, with Google, unveil the most detailed brain map ever
Next article： The high cost of giving birth even with insurance

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

People with mental disorders often marry others with same

Peoplewithmentaldisorders,includingautismandschizophrenia,tendtomarrypartnerswiththesamedisorders,as

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

2:08Sen.TommyTubervillespeakstoreportersintheSenatesubwayattheU.S.CapitolJuly10,2023inWashington,DC.

fashion

focus

knowledge

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist